Investors are a funny bunch. Private hospital group Mediclinic International’s disappointing offshore ventures have meant it has shed more than 70% of its value in the past three years while its senior executives continued to get generous bonuses with barely a murmur from shareholders.

But there is growing disquiet among a minority of institutional investors, and the company may face tough questions at its AGM later this month.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00.